John M. Bedtelyon

Array ( [id] => 9401912 [patent_doc_number] => 08691965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Oligonucleotides for modulating target RNA activity' [patent_app_type] => utility [patent_app_number] => 12/664502 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12249 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599700 [patent_doc_number] => 07582747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'siRNA targeting inner centromere protein antigens (INCENP)' [patent_app_type] => utility [patent_app_number] => 12/157151 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34437 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582747.pdf [firstpage_image] =>[orig_patent_app_number] => 12157151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496311 [patent_doc_number] => 20100010065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Methods and Compositions for Cellular Reprogramming' [patent_app_type] => utility [patent_app_number] => 12/124943 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22533 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20100010065.pdf [firstpage_image] =>[orig_patent_app_number] => 12124943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960570 [patent_doc_number] => 20080274995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Suppression of Nuclear Factor-KappaB Dependent Processes Using Oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/115373 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8352 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274995.pdf [firstpage_image] =>[orig_patent_app_number] => 12115373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564653 [patent_doc_number] => 20090137506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)' [patent_app_type] => utility [patent_app_number] => 12/114698 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 112850 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137506.pdf [firstpage_image] =>[orig_patent_app_number] => 12114698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758886 [patent_doc_number] => 20080311112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OR PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/104816 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9844 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311112.pdf [firstpage_image] =>[orig_patent_app_number] => 12104816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111967 [patent_doc_number] => 07718631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Treatment tool for cancer: RNA interference of BCAS2' [patent_app_type] => utility [patent_app_number] => 12/062478 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3666 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718631.pdf [firstpage_image] =>[orig_patent_app_number] => 12062478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645250 [patent_doc_number] => 20100227914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'RNA Antagonist Compounds for the Inhibition of Apo-B100 Expression' [patent_app_type] => utility [patent_app_number] => 12/532275 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13513 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227914.pdf [firstpage_image] =>[orig_patent_app_number] => 12532275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703897 [patent_doc_number] => 08828959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells' [patent_app_type] => utility [patent_app_number] => 12/050586 [patent_app_country] => US [patent_app_date] => 2008-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 23 [patent_no_of_words] => 6127 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12050586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634496 [patent_doc_number] => 08012947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Methods and compositions for promoting wound healing' [patent_app_type] => utility [patent_app_number] => 12/047106 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 16873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012947.pdf [firstpage_image] =>[orig_patent_app_number] => 12047106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711133 [patent_doc_number] => 20080299659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING APOB GENE EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/039668 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 37488 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299659.pdf [firstpage_image] =>[orig_patent_app_number] => 12039668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967161 [patent_doc_number] => 07939652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases' [patent_app_type] => utility [patent_app_number] => 12/072941 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939652.pdf [firstpage_image] =>[orig_patent_app_number] => 12072941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664159 [patent_doc_number] => 20080255066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDE STRATEGIES FOR THE ENHANCEMENT OF CANCER THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/029297 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22465 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255066.pdf [firstpage_image] =>[orig_patent_app_number] => 12029297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122173 [patent_doc_number] => 07709630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Antisense modulation of connective tissue growth factor expression' [patent_app_type] => utility [patent_app_number] => 12/011761 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33170 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709630.pdf [firstpage_image] =>[orig_patent_app_number] => 12011761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336681 [patent_doc_number] => 20090053145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'ANTI-VIRAL COMPOSITIONS AND METHODS OF USE IN CATTLE' [patent_app_type] => utility [patent_app_number] => 12/020992 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13329 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053145.pdf [firstpage_image] =>[orig_patent_app_number] => 12020992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927902 [patent_doc_number] => 20080167265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'MODULATION OF FR-ALPHA EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/971027 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21591 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167265.pdf [firstpage_image] =>[orig_patent_app_number] => 11971027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321804 [patent_doc_number] => 20100113559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Chitosan Based Polymer Conjugate and a Method for Producing the Same' [patent_app_type] => utility [patent_app_number] => 12/522215 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17592 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113559.pdf [firstpage_image] =>[orig_patent_app_number] => 12522215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436212 [patent_doc_number] => 20090170799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'MODULATION OF C-REACTIVE PROTEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969208 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49343 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170799.pdf [firstpage_image] =>[orig_patent_app_number] => 11969208 [rel_patent_id] =>[rel_patent_doc_number] =>)